Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Doctors remain the gold standard for cancer info, but trust in health agencies has slipped post-pandemic. A survey of 17,000+ Americans found physician trust held steady at ~96%, while confidence in the CDC, NIH, and similar bodies dropped notably. Experts warn this erosion could lead patients to skip cancer screenings and ignore key health guidance.
Physicians remain the most trusted source of cancer information for American patients — but the same can't be said for government health agencies. A new study using the NCI's Health Information National Trends Survey found that 95.7% of respondents trusted cancer information from their doctors before the pandemic, and that figure has barely budged since. That's the good news.
The not-so-good news: trust in agencies like the CDC, NIH, and FDA has meaningfully declined since COVID-19. Researchers say poor health communication during the pandemic is largely to blame, and the damage has lingered well past the WHO's official end of the pandemic in early 2023.
The stakes are real. Patients who distrust health institutions are less likely to get cancer screenings, skip genetic testing, and are harder to keep on treatment. Experts are urging physicians to step up as proactive messengers — reinforcing agency recommendations directly with patients.
By the Numbers:
Why it matters: As trust in public health institutions erodes, physicians become the last line of defense for delivering accurate cancer guidance. Doctors who proactively reinforce screening recommendations and agency guidelines could help fill a growing credibility gap — and potentially save lives.